These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17092778)

  • 1. QSPR modeling of the half-wave potentials of benzoxazines by optimal descriptors calculated with the SMILES.
    Toropov A; Nesmerak K; Raska I; Waisser K; Palat K
    Comput Biol Chem; 2006 Dec; 30(6):434-7. PubMed ID: 17092778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
    Toropov AA; Toropova AP; Raska I
    Eur J Med Chem; 2008 Apr; 43(4):714-40. PubMed ID: 17629592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMILES-based quantitative structure-property relationships for half-wave potential of N-benzylsalicylthioamides.
    Nesmerak K; Toropov AA; Toropova AP; Kohoutova P; Waisser K
    Eur J Med Chem; 2013 Sep; 67():111-4. PubMed ID: 23850571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSPR modeling bioconcentration factor (BCF) by balance of correlations.
    Toropov AA; Toropova AP; Benfenati E
    Eur J Med Chem; 2009 Jun; 44(6):2544-51. PubMed ID: 19232785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSPR modeling of enthalpies of formation for organometallic compounds by SMART-based optimal descriptors.
    Toropov AA; Toropova AP; Benfenati E; Manganaro A
    J Comput Chem; 2009 Nov; 30(15):2576-82. PubMed ID: 19373829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. coral Software: QSAR for Anticancer Agents.
    Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
    Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CORAL: quantitative structure-activity relationship models for estimating toxicity of organic compounds in rats.
    Toropova AP; Toropov AA; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    J Comput Chem; 2011 Sep; 32(12):2727-33. PubMed ID: 21656789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR modeling of acute toxicity by balance of correlations.
    Toropov AA; Rasulev BF; Leszczynski J
    Bioorg Med Chem; 2008 Jun; 16(11):5999-6008. PubMed ID: 18482841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations.
    Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
    J Comput Chem; 2010 Jan; 31(2):381-92. PubMed ID: 19479738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CORAL: building up the model for bioconcentration factor and defining it's applicability domain.
    Toropov AA; Toropova AP; Lombardo A; Roncaglioni A; Benfenati E; Gini G
    Eur J Med Chem; 2011 Apr; 46(4):1400-3. PubMed ID: 21295893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CORAL: QSPR model of water solubility based on local and global SMILES attributes.
    Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jan; 90(2):877-80. PubMed ID: 22921649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSPR modelling of dielectric constants of π-conjugated organic compounds by means of the CORAL software.
    Achary PG
    SAR QSAR Environ Res; 2014; 25(6):507-26. PubMed ID: 24716837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMILES in QSPR/QSAR Modeling: results and perspectives.
    Toropov AA; Benfenati E
    Curr Drug Discov Technol; 2007 Aug; 4(2):77-116. PubMed ID: 17691912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells.
    Toropov AA; Toropova AP; Puzyn T; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jun; 92(1):31-7. PubMed ID: 23566368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative structure activity relationship models based on heuristic method and gene expression programming for the prediction of the pK(a) values of sulfa drugs].
    Li YQ; Si HZ; Xiao YL; Liu CH; Xia CC; Li K; Qi YX
    Yao Xue Xue Bao; 2009 May; 44(5):486-90. PubMed ID: 19618723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMILES-based optimal descriptors: QSAR modeling of carcinogenicity by balance of correlations with ideal slopes.
    Toropov AA; Toropova AP; Benfenati E
    Eur J Med Chem; 2010 Sep; 45(9):3581-7. PubMed ID: 20570021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMILES as an alternative to the graph in QSAR modelling of bee toxicity.
    Toropov AA; Benfenati E
    Comput Biol Chem; 2007 Feb; 31(1):57-60. PubMed ID: 17275412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    Toropov AA; Toropova AP; Raska I; Benfenati E
    Eur J Med Chem; 2010 Apr; 45(4):1639-47. PubMed ID: 20106561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSPR modeling of flash points: an update.
    Katritzky AR; Stoyanova-Slavova IB; Dobchev DA; Karelson M
    J Mol Graph Model; 2007 Sep; 26(2):529-36. PubMed ID: 17532242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.